首页> 中文期刊> 《局解手术学杂志》 >补救性肝移植和再次肝切除治疗肝癌术后复发的疗效对比

补救性肝移植和再次肝切除治疗肝癌术后复发的疗效对比

         

摘要

Objective To evaluate the curative effect of salvage liver transplantation and repeated hepatectomy for recurrent hepatocel-lular carcinoma.Methods The data of 72 patients with recurrent hepatocellular carcinoma fulfilling Child-Pugh A and the Milan criteria from September 2004 to August 2010 were retrospectively studied.According to different treatments,53 patients were divided into repeated hepatec-tomy group,and 19 patients were divided into salvage liver transplantation group.The overall survival rates and disease-free survival rates after operation were evaluated by Kaplan-Meier method.COX proportional hazard was used for univariate analysis and multivariate analysis to eval-uate the risk factors for prognosis.Results The 1-year,3-year and 5-year survival rates were 86.79%,62.26% and 45.28% in repeated hepatectomy group,and 89.47%,68.42%and 57.89% in the salvage liver transplantation group respectively.There was no significant differ-ence in the overall survival rates between the two groups (χ2 =2.530,P =0.112).The 1-year,3-year and 5-year disease-free survival rates were 67.92%,47.17% and 35.85%in the repeated hepatectomy group,94.74%,68.42% and 52.63% in the salvage liver transplantation group respectively.There was a significant difference in the disease-free survival rates between the two groups(χ2 =4.395,P =0.036).The univariate analysis and multivariate analysis indicated that microvascular invasion,satellite lesion and multiple tumors were the independent risk factors to influence the survival.Conclusion The salvage liver transplantation obtains a better effect for the patients fulfilling Child-Pugh A and the Milan criteria,which is an effective method in the treatment of hepatocellular carcinoma.%目的:探讨补救性肝移植和再次肝切除治疗肝癌切除术后复发的疗效。方法回顾性分析2004年9月至2010年8月72例符合米兰标准且肝功能为 Child A 肝癌复发患者的资料,依据手术方式不同分为再次肝切除组(53例)和补救性肝移植组(19例)。Kaplan-Meier 曲线检验2组患者肝癌切除术后复发的术后生存率和术后无瘤生存率的差异。COX 比例风险回归模型分析影响复发患者再次手术后生存的因素。结果再次肝切除组1年、3年、5年生存率为86.79%、62.26%、45.28%,补救性肝移植组治疗1年、3年、5年生存率为89.47%、68.42%、57.89%,2组比较差异无统计学意义(χ2=2.530,P =0.112);再次肝切除术组1年、3年、5年无瘤生存率分别为67.92%、47.17%、35.85%,补救性肝移植组1年、3年、5年无瘤生存率分别为94.74%、68.42%、52.63%,2组比较差异有统计学意义(χ2=4.395,P =0.036)。单因素和多因素分析结果显示,微血管侵犯、卫星灶和肿瘤多发影响肝癌术后复发再次术后生存的独立危险因素。结论当肝癌术后复发符合米兰标准且肝功能为 Child A 时,补救性肝移植可取得稍优于再次肝切除治疗的效果,行补救性肝移植是一种可行有效的治疗方法。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号